| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner | 10% Owner
5 companies
Manning Paul B is a 10% Owner at Acumen Pharmaceuticals, Inc. with holdings across 5 companies. Recent SEC Form 4 filings include 16 buys and 0 sells.
Estimated insider holdings value: $91.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 24, 2023 | VRCA Verrica Pharmaceuticals Inc. | Director, 10% Owner | Buy | 200,000 | $5.02 | $1,004,000.00 | +2.6% | -30.7% | +46.8% | |
| Oct 31, 2022 | TSHA Taysha Gene Therapies, Inc. | Director, 10% Owner | Buy | 1,500,000 | $2.00 | $3,000,000.00 | +1,055% | -10.5% | +36.0% | |
| Jul 5, 2022 | VRCA Verrica Pharmaceuticals Inc. | Director, 10% Owner | Buy | 4,761,904 | $2.10 | $9,999,998.40 | +53.6% | +19.6% | +136.8% | |
| Apr 18, 2022 | LQDA Liquidia Corp | Director | Buy | 392,156 | $5.10 | $1,999,995.60 | New | -27.4% | +35.8% | |
| Feb 3, 2022 | TSHA Taysha Gene Therapies, Inc. | Director, 10% Owner | Buy | 201,602 | $7.80 | $1,571,809.68 | +4.8% | -45.1% | -84.4% | |
| Dec 3, 2021 | VRCA Verrica Pharmaceuticals Inc. | Director, 10% Owner | Buy | 50,000 | $9.36 | $467,905.29 | +0.3% | -9.0% | -63.7% | |
| Nov 24, 2021 | TSHA Taysha Gene Therapies, Inc. | Director, 10% Owner | Buy | 2,202 | $13.19 | $29,044.38 | +6.9% | -54.3% | -82.6% | |
| Nov 23, 2021 | TSHA Taysha Gene Therapies, Inc. | Director, 10% Owner | Buy | 20,000 | $12.54 | $250,800.00 | +166.7% | -52.3% | -81.8% | |
| Jul 29, 2021 | CADL Candel Therapeutics, Inc. | Director | Buy | 56,000 | $7.34 | $410,778.00 | +155.6% | +57.5% | -57.5% | |
| Jul 6, 2021 | ABOS Acumen Pharmaceuticals, Inc. | 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +10.3% | -25.0% | -72.8% |